Democrats’ recent electoral victory may significantly affect negotiations regarding the funding for the Food and Drug Administration (FDA), particularly through the influence of Senator Bernie Sanders (I-VT). The FDA relies on user fees from pharmaceutical companies to finance its drug review processes. The Prescription User Fee Drug Act must be renewed before its expiration on September 30, or it could hinder the FDA’s capacity to approve new medicines.
As a senior Democrat likely to lead the Senate’s health committee, Sanders has been a vocal critic of the user fee structure. His position may lead to substantial changes in how the FDA is funded, which could impact pharmaceutical companies’ operations and drug approval timelines.
Source: statnews.com · Image: FDA Bldg 64 – Exterior (5161375466) by The U.S. Food and Drug Administration, Public domain, via Wikimedia Commons
Start your 7-day trial and see what the database can do →
